View Older Stories View More Recent Stories
-
Shopify (SHOP) PT Raised to $127 at Roth Capital on Investor Meetings; 'Remain Positive on Shares'
-
Roth Capital Upgrades Maxwell Technologies (MXWL ) to Buy Citing Favorable Risk/Reward
-
Roth Capital Starts Aimmune Therapeutics (AIMT) at Buy
-
Roth Capital Downgrades Pointer Telocation (PNTR) to Neutral Citing Valuation
-
Century Casinos (CNTY) Prices 4.25M Common Stock Offering at $7.50/Share
-
Century Casinos Announces Pricing of Public Offering of Common Stock
-
Veritone, Inc. (VERI) Prices 975K Share Common Offering at $23/Sh
-
Veritone, Inc. Announces Pricing of Public Offering of Common Stock
-
SenesTech, Inc. (SNES) Prices Offering of Common Stock and Warrants
-
SenesTech Announces Pricing of Public Offering of Common Stock and Warrants to Purchase Common Stock
-
Century Casinos (CNTY) Plans Common Stock Offering
-
Century Casinos Announces Proposed Public Offering of Common Stock
-
Daqo New Energy (DQ) PT Raised to $50 at Roth Capital
-
Celsius Holdings to Present at Upcoming Investor Conferences
-
Netlist (NLST) PT Lowered to $1 at Roth Capital; 'Hynix Litigation Opportunity Remains'
-
Pre-Open Movers 11/15: (SORL) (CARG) (BCEI) Higher; (ACOR) (VERI) (MTSI) Lower (more...)
-
Veritone, Inc. (VERI) Falls Amid Plans to Offer 800K Shares
-
Sunworks (SUNW) PT Lowered to $2 at Roth Capital
-
UPDATE: Roth Capital Starts Albireo Pharma (ALBO) at Buy
-
UPDATE: Roth Capital Starts Galmed Pharmaceuticals (GLMD) at Buy
-
Remark Media (MARK) PT Raised to $10.25 at Roth Capital (Earlier)
-
Galectin Therapeutics (GALT) PT Raised to $10 at Roth Capital
-
Redhill Biopharma (RDHL) PT Lowered to $20 at Roth Capital Following 3Q Release
-
Myomo (MYO) Files Registration Statement for Proposed Follow-On Offering
-
Myomo, Inc. Files Registration Statement for Proposed Follow-On Offering
-
RedHill Biopharma Announces Closing of Public Offering of its American Depositary Shares
-
RedHill Biopharma Announces Closing of Public Offering of its American Depositary Shares
-
RedHill Biopharma Reports 2017 Third Quarter Financial Results
-
RedHill Biopharma Reports 2017 Third Quarter Financial Results
-
Roth Capital Downgrades Sequential Brands (SQBG) to Neutral
-
Plug Power (PLUG) Q3 'Weak', 60% of Sales to Wal-Mart and Amazon Were Paid with Warrant 'Gift' - Roth
-
Pre-Open Movers 11/10: (JCP) (DVAX) (HTZ) Higher; (TTD) (QTM) (GBT) Lower (more...)
-
Roth Capital Upgrades Canadian Solar (CSIQ) to Buy Citing Strength of Management Execution
-
Roth Capital Downgrades Titan Pharmaceuticals (TTNP) to Neutral Citing Probuphine Ramp Delay
-
FORM Holdings Reports Third Quarter 2017 Results
-
Roth Capital Upgrades The Hackett Group (HCKT) to Buy
-
Pixelworks to Participate at Upcoming November Financial Conferences
-
ROTH Capital Partners Announces the Addition of Murray Huneke, Managing Director, Co-Head of Consumer Investment Banking
-
Roth Capital Downgrades CECO Environmental (CECE) to Neutral Citing Limited Visibility
-
MeetMe (MEET) PT Lowered to $4 at Roth Capital
-
SenesTech, Inc. (SNES) Plans Public Offering of Common Stock
-
SenesTech Announces Public Offering of Common Stock
-
Roth Encourages Investors to Accumulate a Position in Trevena (TRVN)
-
RedHill Biopharma (RDHL) Prices 4.1M ADS Offering at $5.50/Sh
-
RedHill Biopharma Prices Public Offering of its American Depositary Shares
-
RedHill Biopharma Prices Public Offering of its American Depositary Shares
-
Roth Capital Downgrades RMG Networks Holding (RMGN) to Neutral
-
Digital Ally (DGLY) Says It's Exploring Strategic Alternatives
-
Digital Ally Exploring Strategic Alternatives
-
Roth Capital Resumes Cogentix Medical (CGNT) at Buy

